174 related articles for article (PubMed ID: 10944827)
1. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
3. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
4. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
[TBL] [Abstract][Full Text] [Related]
5. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
Suwaki T; Agrawal DK; Townley RG
Int Immunopharmacol; 2001 Nov; 1(12):2163-71. PubMed ID: 11710545
[TBL] [Abstract][Full Text] [Related]
6. Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice.
Shim JJ; Dabbagh K; Takeyama K; Burgel PR; Dao-Pick TP; Ueki IF; Nadel JA
J Allergy Clin Immunol; 2000 Apr; 105(4):739-45. PubMed ID: 10756224
[TBL] [Abstract][Full Text] [Related]
7. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
8. Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects.
Agrawal DK; Cheng G; Kim MJ; Kiniwa M
Clin Exp Allergy; 2008 Feb; 38(2):305-12. PubMed ID: 18028459
[TBL] [Abstract][Full Text] [Related]
9. Th2 cytokine inhibitor suplatast tosilate inhibits antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats.
Shimizu S; Hattori R; Majima Y; Shimizu T
Ann Otol Rhinol Laryngol; 2009 Jan; 118(1):67-72. PubMed ID: 19244966
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
11. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
12. Progress in suplatast tosilate research.
Sano Y; Yamada H
Clin Exp Allergy; 2007 Jul; 37(7):970-2. PubMed ID: 17581190
[No Abstract] [Full Text] [Related]
13. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
14. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
Shioya T; Satake M; Sano M; Kagaya M; Watanabe A; Sato K; Ito T; Ito N; Sasaki M; Miura M
Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601
[TBL] [Abstract][Full Text] [Related]
15. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
Mizuguchi H; Orimoto N; Kadota T; Kominami T; Das AK; Sawada A; Tamada M; Miyagi K; Adachi T; Matsumoto M; Kosaka T; Kitamura Y; Takeda N; Fukui H
J Pharmacol Sci; 2016 Mar; 130(3):151-8. PubMed ID: 26874672
[TBL] [Abstract][Full Text] [Related]
16. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
[TBL] [Abstract][Full Text] [Related]
17. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
[TBL] [Abstract][Full Text] [Related]
18. Increase effect of transforming growth factor on eotaxin production by normal cultured dermal fibroblasts stimulated with interleukin-4: inhibitory effect of suplatast tosilate on eotaxin production.
Bae SJ; Lee JB; Shimizu K; Kuwazuka Y
Immunol Invest; 2010 Jan; 39(2):93-102. PubMed ID: 20136617
[TBL] [Abstract][Full Text] [Related]
19. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
[TBL] [Abstract][Full Text] [Related]
20. The effects of suplatast tosilate treatment and prophylaxis on lung histopathology in a mouse model of chronic asthma.
Tuncel T; Karaman M; Ayyildiz ZA; Uysal P; Kiray M; Bagriyanik AH; Yilmaz O; Karaman O; Uzuner N
J Investig Med; 2014 Jan; 62(1):56-61. PubMed ID: 24113733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
